These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 29175838)

  • 21. Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days.
    Kopp Kallner H; Fiala C; Stephansson O; Gemzell-Danielsson K
    Hum Reprod; 2010 May; 25(5):1153-7. PubMed ID: 20172871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medical Compared With Surgical Abortion for Effective Pregnancy Termination in the First Trimester.
    Ireland LD; Gatter M; Chen AY
    Obstet Gynecol; 2015 Jul; 126(1):22-8. PubMed ID: 26241252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Signs and symptoms associated with early pregnancy loss: findings from a population-based preconception cohort.
    Sapra KJ; Buck Louis GM; Sundaram R; Joseph KS; Bates LM; Galea S; Ananth CV
    Hum Reprod; 2016 Apr; 31(4):887-96. PubMed ID: 26936888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accuracy of a semi-quantitative urine pregnancy test compared to serum beta-hCG measurement: a possible screening tool for ongoing pregnancy after medication abortion.
    Grossman D; Berdichevsky K; Larrea F; Beltran J
    Contraception; 2007 Aug; 76(2):101-4. PubMed ID: 17656178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of missed abortion: comparison of medical treatment with either mifepristone + misoprostol or misoprostol alone with surgical evacuation. A multi-center trial in Copenhagen county, Denmark.
    Grønlund A; Grønlund L; Clevin L; Andersen B; Palmgren N; Lidegaard Ø
    Acta Obstet Gynecol Scand; 2002 Nov; 81(11):1060-5. PubMed ID: 12421175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HCG, progesterone and 17-beta-estradiol levels during extra-amniotically induced early abortion by a new prostaglandin derivative (Sulprostone).
    Nilsson S; Zador G; Nygren KG; Wide L
    Gynecol Obstet Invest; 1981; 12(4):203-10. PubMed ID: 7250783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the beta-Neocept test for early pregnancy.
    Yuen BH; Pride SM; Callegari PB
    Can Med Assoc J; 1984 Sep; 131(6):583-5. PubMed ID: 6206935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abortion surveillance--United States, 2009.
    Pazol K; Creanga AA; Zane SB; Burley KD; Jamieson DJ;
    MMWR Surveill Summ; 2012 Nov; 61(8):1-44. PubMed ID: 23169413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparative study of human chorionic gonadotropin, placebo, and bed rest for women with early threatened abortion.
    Harrison RF
    Int J Fertil Menopausal Stud; 1993; 38(3):160-5. PubMed ID: 8348164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simplified medical abortion using a semi-quantitative pregnancy test for home-based follow-up.
    Lynd K; Blum J; Ngoc NT; Shochet T; Blumenthal PD; Winikoff B
    Int J Gynaecol Obstet; 2013 May; 121(2):144-8. PubMed ID: 23477704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Obstetrical complications associated with abnormal maternal serum markers analytes.
    Gagnon A; Wilson RD;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abortion surveillance - United States, 2010.
    Pazol K; Creanga AA; Burley KD; Hayes B; Jamieson DJ;
    MMWR Surveill Summ; 2013 Nov; 62(8):1-44. PubMed ID: 24280963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Double-blind controlled trial of progesterone substitution in threatened abortion.
    Gerhard I; Gwinner B; Eggert-Kruse W; Runnebaum B
    Biol Res Pregnancy Perinatol; 1987; 8(1 1ST Half):26-34. PubMed ID: 2437967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immediate versus delayed insertion of an etonogestrel releasing implant at medical abortion-a randomized controlled equivalence trial.
    Hognert H; Kopp Kallner H; Cameron S; Nyrelli C; Jawad I; Heller R; Aronsson A; Lindh I; Benson L; Gemzell-Danielsson K
    Hum Reprod; 2016 Nov; 31(11):2484-2490. PubMed ID: 27664217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methotrexate. A single agent for early abortion.
    Schaff EA; Penmetsa U; Eisinger SH; Franks P
    J Reprod Med; 1997 Jan; 42(1):56-60. PubMed ID: 9018647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The value of determinations of human chorionic gonatrophin, human placental lactogen, progesterone and oestriol in women with threatened abortion (author's transl)].
    Gerhard I; Runnebaum B
    Geburtshilfe Frauenheilkd; 1978 Oct; 38(10):785-99. PubMed ID: 700341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Triaging pregnancies of unknown location: the performance of protocols based on single serum progesterone or repeated serum hCG levels.
    Guha S; Ayim F; Ludlow J; Sayasneh A; Condous G; Kirk E; Stalder C; Timmerman D; Bourne T; Van Calster B
    Hum Reprod; 2014 May; 29(5):938-45. PubMed ID: 24634251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A rapid direct latex agglutination test for HCG (author's transl)].
    Spona J
    Wien Klin Wochenschr; 1976 Apr; 88(9):289-91. PubMed ID: 973387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urine beta-core fragment, a potential screening test for ectopic pregnancy and spontaneous abortion.
    Cole LA; Isozaki T; Jones EE
    Fetal Diagn Ther; 1997; 12(6):336-9. PubMed ID: 9475362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of women who present for abortion towards the end of the mid-trimester in Scotland: national audit 2013-2014.
    Cameron ST; Riddell J; Brown A; Thomson A; Melville C; Flett G; Caird L; Laird G
    Eur J Contracept Reprod Health Care; 2016; 21(2):183-8. PubMed ID: 26568404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.